Sleep Apnea Solution author Dylan Petkus, MD, has developed a non-device, behavior-based alternative approach to sleep apnea.

The FDA is moving to speed drug development and review by launching real-time clinical trials, which could mean more options for patients.

The FDA has accepted the NDA for zipalertinib to treat adult patients with locally advanced or metastatic EGFR exon 20 insertion-mutated NSCLC.

The Food and Drug Administration (FDA) has approved Breztri Aerosphere ® (budesonide/glycopyrrolate/formoterol fumarate; BGF) for the maintenance treatment of asthma in adult and ...

Youth cannabis use between ages 9 and 17 years is associated with slower cognitive development during a time of key brain development.

Anxiety and depression are prevalent in patients with IPF and are linked to increased breathlessness and lower energy levels.

In cystic fibrosis, ETI significantly reduced daily cough frequency and increased physical activity levels in patients aged ...